About
Eyenuk, Inc. is a global artificial intelligence medical technology company based in Los Angeles, California, founded in 2010. The company specializes in AI-driven eye screening solutions that autonomously detect vision-threatening diseases and assess predictive health risks. Eyenuk's mission is to enhance predictive and preventative healthcare by analyzing retinal images to facilitate timely diagnoses of conditions such as diabetic retinopathy, glaucoma, and cardiovascular risks. The flagship product, the EyeArt AI Eye Screening System, is an FDA-cleared autonomous system that analyzes retinal images to detect eye diseases without requiring specialist intervention. Eyenuk also develops AI Predictive Biomarkers™ for risk assessment and disease surveillance, aiming to improve access to eye care. The company collaborates with various healthcare providers, including hospitals, clinics, and public health departments, and has partnerships with notable institutions like the Doheny Eye Institute and Cedars Sinai. Eyenuk is recognized as a leader in AI eye screening technology, demonstrating strong growth and adoption of its solutions in the healthcare market.
Technologies
Keywords
Company Information
-
Employees 23
-
Founded 2010
-
Annual Revenue $6000000
-
Total Funding $66732541
Location
5850 Canoga Ave, Los Angeles, California, United States, 91367
